ABBV Nov 2024 110.000 call
| Previous close | 45.75 |
| Open | 44.00 |
| Bid | 59.50 |
| Ask | 64.00 |
| Strike | 110.00 |
| Expiry date | 2024-11-15 |
| Day's range | 44.00 - 45.75 |
| Contract range | N/A |
| Volume | |
| Open interest | 3 |
ZacksAbbVie (ABBV) Suffers a Larger Drop Than the General Market: Key Insights
AbbVie (ABBV) closed the most recent trading day at $195.45, moving -0.7% from the previous trading session.
ReutersAbbVie cuts 2024 profit forecast citing R&D expenses
AbbVie on Thursday lowered its forecast for 2024 adjusted profit, citing the impact of $82 million in milestones, and research and development expenses related to acquisitions. The drugmaker expects annual adjusted profit per share in the range of $10.67 to $10.87, compared with its previous forecast of $10.71 to $10.91 per share, a regulatory filing showed. Analysts were expecting $10.88 per share, according to estimates compiled by LSEG.
Insider MonkeyPGIM Jennison Health Sciences Fund Sold AbbVie (ABBV) in Q2. Here’s Why
PGIM Jennison Health Sciences Fund released its second quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund modestly underperformed the S&P 1500 Health Care Index in the quarter which declined 1.1%. Security selection within pharmaceuticals, MedTech, and health care provides & services contributed the most value during the quarter, […]
